All Stories

  1. P53: A key player in diverse cellular processes including nuclear stress and ribosome biogenesis, highlighting potential therapeutic compounds
  2. Tapping into Nature’s Arsenal: Harnessing the Potential of Natural Antioxidants for Human Health and Disease Prevention
  3. Advances in molecular function of UPF1 in Cancer
  4. Cellular Basis of Adjuvant Role of n-3 Polyunsaturated Fatty Acids in Cancer Therapy: Molecular Insights and Therapeutic Potential against Human Melanoma
  5. Propranolol Promotes Monocyte-to-Macrophage Differentiation and Enhances Macrophage Anti-Inflammatory and Antioxidant Activities by NRF2 Activation
  6. An insight into role of amino acids as antioxidants via NRF2 activation
  7. The Potential Role of Major Argan Oil Compounds as Nrf2 Regulators and Their Antioxidant Effects
  8. Novel Multi-Antioxidant Approach for Ischemic Stroke Therapy Targeting the Role of Oxidative Stress
  9. E-Stilbenes: General Chemical and Biological Aspects, Potential Pharmacological Activity Based on the Nrf2 Pathway
  10. Redox Homeostasis and Nrf2-Regulated Mechanisms Are Relevant to Male Infertility
  11. Exploring antioxidant strategies in the pathogenesis of ALS
  12. An intricate rewiring of cancer metabolism via alternative splicing
  13. A Review of the Potential of Nuclear Factor [Erythroid-Derived 2]-like 2 Activation in Autoimmune Diseases
  14. Pharmacological Modulation of Oxidative Stress
  15. Potential Role of Natural Antioxidants in Countering Reperfusion Injury in Acute Myocardial Infarction and Ischemic Stroke
  16. Oxidative Stress as a Regulatory Checkpoint in the Production of Antiphospholipid Autoantibodies: The Protective Role of NRF2 Pathway
  17. 5-Oxohexahydroquinolines bearing 4-pyridyl methyl carboxylate as P-glycoprotein inhibitors and multidrug resistance reversal agents in cancer cells
  18. Novel spiroindoline quinazolinedione derivatives as anticancer agents and potential FLT3 kinase inhibitors
  19. Infection Meets Inflammation: N6-Methyladenosine, an Internal Messenger RNA Modification as a Tool for Pharmacological Regulation of Host–Pathogen Interactions
  20. Alkaloids as Natural NRF2 Inhibitors: Chemoprevention and Cytotoxic Action in Cancer
  21. Therapeutic potential of marine peptides in malignant melanoma
  22. Cancer Prevention and Therapy by Targeting Oxidative Stress Pathways
  23. Circulating Serum VEGF, IGF-1 and MMP-9 and Expression of Their Genes as Potential Prognostic Markers of Recovery in Post-Stroke Rehabilitation—A Prospective Observational Study
  24. Chemical, Biological and Biomedical Aspects of Bioantioxidants
  25. Marine Cyanobacterial Peptides in Neuroblastoma: Search for Better Therapeutic Options
  26. Antioxidant Activity of Coumarins and Their Metal Complexes
  27. The Exosome-Mediated PI3K/Akt/mTOR Signaling Pathway in Neurological Diseases
  28. NRF2 Activation by Nitrogen Heterocycles: A Review
  29. Modulation of Nrf2/HO-1 by Natural Compounds in Lung Cancer
  30. Antioxidant Activity of Natural Phenols and Derived Hydroxylated Biphenyls
  31. Sulfonamide a Valid Scaffold for Antioxidant Drug Development
  32. Endostatin and Cancer Therapy: A Novel Potential Alternative to Anti-VEGF Monoclonal Antibodies
  33. Recoding of Nonsense Mutation as a Pharmacological Strategy
  34. Antioxidant Protection against Trastuzumab Cardiotoxicity in Breast Cancer Therapy
  35. LPS-Activated Microglial Cell-Derived Conditioned Medium Protects HT22 Neuronal Cells against Glutamate-Induced Ferroptosis
  36. Cardioprotective Mechanisms against Reperfusion Injury in Acute Myocardial Infarction: Targeting Angiotensin II Receptors
  37. Regulatory Effects of Curcumin on Platelets: An Update and Future Directions
  38. Nrf2 Pathway in Huntington’s Disease (HD): What Is Its Role?
  39. Potential Antioxidant Multitherapy against Complications Occurring in Sepsis
  40. Recent Advances in Nanomaterials of Group XIV Elements of Periodic Table in Breast Cancer Treatment
  41. Antioxidant Intervention against Male Infertility: Time to Design Novel Strategies
  42. Natural and Synthetic Xanthone Derivatives Counteract Oxidative Stress via Nrf2 Modulation in Inflamed Human Macrophages
  43. NRF2, a crucial modulator of skin cells protection against vitiligo, psoriasis, and cancer
  44. Effect of Curcumin-Loaded Mesoporous Silica Nanoparticles on the Head and Neck Cancer Cell Line, HN5
  45. Neuropeptide Y Promotes Human M2 Macrophage Polarization and Enhances p62/SQSTM1-Dependent Autophagy and NRF2 Activation
  46. Nitro-Oxidative Stress and Mitochondrial Dysfunction in Human Cell Lines Exposed to the Environmental Contaminants PFOA and BPA
  47. Nrf2 Modulation in Breast Cancer
  48. NRF2: A crucial regulator for mitochondrial metabolic shift and prostate cancer progression
  49. Ribosome-Directed Therapies in Cancer
  50. The Role of the NRF2 Pathway in Maintaining and Improving Cognitive Function
  51. Antifungal and Cytotoxic Activity of Diterpenes and Bisnorsesquiterpenoides from the Latex of Euphorbia resinifera Berg
  52. The Challenge of Reaching Undocumented Migrants with COVID-19 Vaccination
  53. NRF2 and Mitochondrial Function in Cancer and Cancer Stem Cells
  54. Human genetic factors associated with pneumonia risk, a cue for COVID-19 susceptibility
  55. An Overview of NRF2-Activating Compounds Bearing α,β-Unsaturated Moiety and Their Antioxidant Effects
  56. Therapeutic Potential of Marine Peptides in Prostate Cancer: Mechanistic Insights
  57. The Therapeutic Potential of Kaemferol and Other Naturally Occurring Polyphenols Might Be Modulated by Nrf2-ARE Signaling Pathway: Current Status and Future Direction
  58. Flavonoids Targeting the mTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti-Breast Cancer Therapy
  59. The Role of Organosulfur Compounds as Nrf2 Activators and Their Antioxidant Effects
  60. How Curcumin Targets Inflammatory Mediators in Diabetes: Therapeutic Insights and Possible Solutions
  61. Ascorbate as a Bioactive Compound in Cancer Therapy: The Old Classic Strikes Back
  62. Modulation of cellular redox environment as a novel therapeutic strategy for Parkinson's disease
  63. Interplay between Non-Coding RNAs and NRF2 in Different Cancers: Spotlight on MicroRNAs and Long Non-Coding RNAs
  64. Ribosomopathies and cancer: pharmacological implications
  65. A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies
  66. Vitamin D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin D and its metabolites
  67. The Role of NRF2/KEAP1 Pathway in Glioblastoma: Pharmacological Implications
  68. Therapeutic Role of Carotenoids in Blood Cancer: Mechanistic Insights and Therapeutic Potential
  69. A Comprehensive Analysis of the Role of Oxidative Stress in the Pathogenesis and Chemoprevention of Oral Submucous Fibrosis
  70. Antioxidant Cardioprotection against Reperfusion Injury: Potential Therapeutic Roles of Resveratrol and Quercetin
  71. The Regulation of Endoplasmic Reticulum Stress in Cancer: Special Focuses on Luteolin Patents
  72. Design, Synthesis, and Biological Evaluation of Novel Tomentosin Derivatives in NMDA-Induced Excitotoxicity
  73. Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response
  74. Evaluation of the radical scavenging activity of some representative isoprenoid and aromatic cytokinin ribosides (N6-substituted adenosines) by in vitro chemical assays
  75. Mechanistic Insight into Oxidative Stress-Triggered Signaling Pathways and Type 2 Diabetes
  76. Alkaloids and Colon Cancer: Molecular Mechanisms and Therapeutic Implications for Cell Cycle Arrest
  77. Pharmaceutical and Pharmacological Aspects of Modulation of Oxidative Stress 2020
  78. A Perspective on Nrf2 Signaling Pathway for Neuroinflammation: A Potential Therapeutic Target in Alzheimer's and Parkinson's Diseases
  79. PFAS Molecules: A Major Concern for the Human Health and the Environment
  80. Synthesis, Crystallographic, Quantum Chemical, Antitumor, and Molecular Docking/Dynamic Studies of 4-Hydroxycoumarin-Neurotransmitter Derivatives
  81. Astaxanthin as a Modulator of Nrf2, NF-κB, and Their Crosstalk: Molecular Mechanisms and Possible Clinical Applications
  82. Probable Reasons for Neuron Copper Deficiency in the Brain of Patients with Alzheimer’s Disease: The Complex Role of Amyloid
  83. Nrf2 Regulation by Curcumin: Molecular Aspects for Therapeutic Prospects
  84. Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile
  85. Nigellidine (Nigella sativa, black-cumin seed) docking to SARS CoV-2 nsp3 and host inflammatory proteins may inhibit viral replication/transcription and FAS-TNF death signal via TNFR 1/2 blocking
  86. The Potential Role of Curcumin in Modulating the Master Antioxidant Pathway in Diabetic Hypoxia-Induced Complications
  87. Polyphenols as Antioxidants for Extending Food Shelf-Life and in the Prevention of Health Diseases: Encapsulation and Interfacial Phenomena
  88. Validating a Genomic Convergence and Network Analysis Approach Using Association Analysis of Identified Candidate Genes in Alzheimer’s Disease
  89. COVID-19: Marking the Gaps in Migrant and Refugee Health in Some Massive Migration Areas
  90. Nuclear Factor Erythroid-2-Related Factor 2 Signaling in the Neuropathophysiology of Inherited Metabolic Disorders
  91. Bcl-2 Modulation in p53 Signaling Pathway by Flavonoids: A Potential Strategy towards the Treatment of Cancer
  92. Multidrug efflux transporter ABCG2: expression and regulation
  93. The Specificity and Broad Multitarget Properties of Ligands for the Free Fatty Acid Receptors FFA3/GPR41 and FFA2/GPR43 and the Related Hydroxycarboxylic Acid Receptor HCA2/GPR109A
  94. Multivariate analysis of polyphenolic content and in vitro antioxidant capacity of wild and cultivated berries from Bosnia and Herzegovina
  95. Joint Cardioprotective Effect of Vitamin C and Other Antioxidants against Reperfusion Injury in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
  96. Oxidative Stress in Mucopolysaccharidoses: Pharmacological Implications
  97. The Nrf2 Pathway in Ischemic Stroke: A Review
  98. Protective Effects of Flavonoids Against Mitochondriopathies and Associated Pathologies: Focus on the Predictive Approach and Personalized Prevention
  99. Evaluation of the Free Radical Scavenging Activities of Ellagic Acid and Ellagic Acid Peracetate by EPR Spectrometry
  100. Pyrido[2′,1′:2,3]imidazo[4,5-c]isoquinolin-5-amines as Potential Cytotoxic Agents against Human Neuroblastoma
  101. Synthesis, Structure and Impact of 5-Aminoorotic Acid and Its Complexes with Lanthanum(III) and Gallium(III) on the Activity of Xanthine Oxidase
  102. Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
  103. Reimagining Internationalization in Higher Education Through the United Nations Sustainable Development Goals for the Betterment of Society
  104. Implications of oxidative stress in chronic kidney disease: a review on current concepts and therapies
  105. Synthesized 2-Trifluoromethylquinazolines and Quinazolinones Protect BV2 and N2a Cells against LPS- and H2O2-induced Cytotoxicity
  106. COVID-19 and migrant and refugee health: A pointer to system competence in future pandemic preparedness
  107. Tamoxifen and oxidative stress: an overlooked connection
  108. Pharmacological Protection against Ischemia-Reperfusion Injury by Regulating the Nrf2-Keap1-ARE Signaling Pathway
  109. Synthesis and Biological Screening of New 4-Hydroxycoumarin Derivatives and Their Palladium(II) Complexes
  110. Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy
  111. Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury
  112. Regulatory Role of Nrf2 Signaling Pathway in Wound Healing Process
  113. The Role of Toxic Metals and Metalloids in Nrf2 Signaling
  114. Profiling Colorectal Cancer in the Landscape Personalized Testing—Advantages of Liquid Biopsy
  115. Natural Chain-Breaking Antioxidants and Their Synthetic Analogs as Modulators of Oxidative Stress
  116. Oxidative Stress, Neuroinflammation, and NADPH Oxidase: Implications in the Pathogenesis and Treatment of Alzheimer’s Disease
  117. The Unity of Redox and Structural Remodeling of Brown Adipose Tissue in Hypothyroidism
  118. Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits
  119. Activation of Nrf2 signaling pathway by natural and synthetic chalcones: a therapeutic road map for oxidative stress
  120. Short overview on the relevance of microRNA–reactive oxygen species (ROS) interactions and lipid peroxidation for modulation of oxidative stress-mediated signalling pathways in cancer treatment
  121. Involvement of NRF2 in Breast Cancer and Possible Therapeutical Role of Polyphenols and Melatonin
  122. Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
  123. Evaluation of the cellular protection by novel spiropyrazole compounds in dopaminergic cell death
  124. The Role of Prokineticin 2 in Oxidative Stress and in Neuropathological Processes
  125. Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion
  126. Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met
  127. Insight into the Biological Activity of Hennosides—Glucosides Isolated from Lawsonia inermis (henna): Could They Be Regarded as Active Constituents Instead
  128. Beneficial Effect of Melatonin on Motor and Memory Disturbances in 6-OHDA-Lesioned Rats
  129. Flavonoids Targeting HIF-1: Implications on Cancer Metabolism
  130. Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice
  131. Antioxidant and Biological Activities of Hydroxytyrosol and Homovanillic Alcohol Obtained from Olive Mill Wastewaters of Extra-Virgin Olive Oil Production
  132. Anti-Viral Potential and Modulation of Nrf2 by Curcumin: Pharmacological Implications
  133. New trends in the pharmacological intervention of PPARs in obesity: Role of natural and synthetic compounds_
  134. An Overview of Nrf2 Signaling Pathway and Its Role in Inflammation
  135. In Vitro Interaction of 5-Aminoorotic Acid and Its Gallium(III) Complex with Superoxide Radical, Generated by Two Model Systems
  136. Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention
  137. Lanthanide (III) complexes of bis-coumarins as strong inhibitors of bovine xanthine oxidase - molecular docking and SAR studies
  138. Astaxanthin targets PI3K/Akt signaling pathway toward potential therapeutic applications
  139. Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2
  140. Genetic Landscape of Common Epilepsies: Advancing towards Precision in Treatment
  141. Lupeol Counteracts the Proinflammatory Signalling Triggered in Macrophages by 7-Keto-Cholesterol: New Perspectives in the Therapy of Atherosclerosis
  142. Kaempferol as a Dietary Anti-Inflammatory Agent: Current Therapeutic Standing
  143. Ellagic Acid-Derived Urolithins as Modulators of Oxidative Stress
  144. Antioxidant Activity of Synthetic Polymers of Phenolic Compounds
  145. Modulators of Oxidative Stress: Chemical and Pharmacological Aspects
  146. Natural Sources, Pharmacokinetics, Biological Activities and Health Benefits of Hydroxycinnamic Acids and Their Metabolites
  147. Synthesis, In Vitro Antioxidant Properties and Distribution of a New Cyanothiophene-Based Phenolic Compound in Olive Oil-In-Water Emulsions
  148. Interaction of 2,6,7-Trihydroxy-Xanthene-3-Ones with Iron and Copper, and Biological Effect of the Most Active Derivative on Breast Cancer Cells and Erythrocytes
  149. The NRF2/KEAP1 Axis in the Regulation of Tumor Metabolism: Mechanisms and Therapeutic Perspectives
  150. Diverse and Complex Challenges to Migrant and Refugee Mental Health: Reflections of the M8 Alliance Expert Group on Migrant Health
  151. Influence of Oxidative Stress on Catalytic and Non-glycolytic Functions of Glyceraldehyde-3-phosphate Dehydrogenase
  152. Chemistry and Pharmacology of Modulators of Oxidative Stress
  153. 5-Oxo-hexahydroquinoline Derivatives and Their Tetrahydroquinoline Counterparts as Multidrug Resistance Reversal Agents
  154. Oxidative stress and endoplasmic stress in calcium oxalate stone disease: the chicken or the egg?
  155. Potential Applications of NRF2 Modulators in Cancer Therapy
  156. Downregulation of peripheral PTGS2/COX-2 in response to valproate treatment in patients with epilepsy
  157. The Effects of Trifluoromethylated Derivatives on Prostaglandin E2 and Thromboxane A2 Production in Human Leukemic U937 Macrophages
  158. The Interaction of Flavonols with Membrane Components: Potential Effect on Antioxidant Activity
  159. The pharmacokinetics of flavanones
  160. Prior Activation of 5-HT7 Receptors Modulates the Conditioned Place Preference With Methylphenidate
  161. HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers
  162. Oxidative Stress: Role and Response of Short Guanine Tracts at Genomic Locations
  163. Post-translational modifications of proteins in antiphospholipid antibody syndrome
  164. Global Text Mining and Development of Pharmacogenomic Knowledge Resource for Precision Medicine
  165. Reduced adolescent risk-assessment and lower nicotinic beta-2 expression in rats exposed to nicotine through lactation by forcedly drinking dams
  166. Modulation of Oxidative Stress: Pharmaceutical and Pharmacological Aspects 2018
  167. Renoprotective effect of tectorigenin glycosides isolated from Iris spuria L. (Zeal) against hyperoxaluria and hyperglycemia in NRK-49Fcells
  168. Topology-Dependent Dissociation Mode of the O–H Bond in Monohydroxycoumarins
  169. Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate Cells
  170. Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs
  171. Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk
  172. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
  173. Potential Applications of NRF2 Inhibitors in Cancer Therapy
  174. Regulation of the Nrf2 Pathway by Glycogen Synthase Kinase-3β in MPP+-Induced Cell Damage
  175. Antioxidant Activities of Alkyl Substituted Pyrazine Derivatives of Chalcones—In Vitro and In Silico Study
  176. The influence of alkaloids on oxidative stress and related signaling pathways
  177. Critical reflections, challenges and solutions for migrant and refugee health: 2nd M8 Alliance Expert Meeting
  178. Viral Induced Oxidative and Inflammatory Response in Alzheimer’s Disease Pathogenesis with Identification of Potential Drug Candidates: A Systematic Review using Systems Biology Approach
  179. Relation of Redox and Structural Alterations of Rat Skin in the Function of Chronological Aging
  180. Synthesis and Characterization of 3-(1-((3,4-Dihydroxyphenethyl)amino)ethylidene)-chroman-2,4-dione as a Potential Antitumor Agent
  181. Screening Pyridine Derivatives against Human Hydrogen Sulfide-synthesizing Enzymes by Orthogonal Methods
  182. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells
  183. Behaviour of 9-Ethyl-9H-carbazole Hydrazone Derivatives Against Oxidant Systems
  184. Antioxidant Properties of Synthesized Bicyclic Thiazolopyrimidine Derivatives as Possible Therapeutic Agents
  185. Modulation of ERK1/2 and Akt Pathways Involved in the Neurotrophic Action of Caffeic Acid Alkyl Esters
  186. Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review
  187. Searching for inhibitors of human H 2 S-synthesizing enzymes by orthogonal methods
  188. Potential Use of Modulators of Oxidative Stress as Add-on Therapy in Patients with Anxiety Disorders
  189. Protective effects of new antioxidant compositions of 4‐methylcoumarins and related compounds with dl‐α‐tocopherol and l‐ascorbic acid
  190. Mono and dihydroxy coumarin derivatives: Copper chelation and reduction ability
  191. 9-(4'-dimethylaminophenyl)-2,6,7-trihydroxy-xanthene-3-one is a Potentially Novel Antiplatelet Drug which Antagonizes the Effect of Thromboxane A2
  192. Efficient synthesis and first regioselective C-6 direct arylation of imidazo[2,1- c ][1,2,4]triazine scaffold and their evaluation in H 2 O 2 -induced oxidative stress
  193. Inhibition of Shiga toxin-converting bacteriophage development by novel antioxidant compounds
  194. Nonylphenol and Octylphenol Differently Affect Cell Redox Balance by Modulating the Nitric Oxide Signaling
  195. Oxidative Stress Induces HSP90 Upregulation on the Surface of Primary Human Endothelial Cells: Role of the Antioxidant 7,8-Dihydroxy-4-methylcoumarin in Preventing HSP90 Exposure to the Immune System
  196. In Vitro Assessment of the Effect of Antiepileptic Drugs on Expression and Function of ABC Transporters and Their Interactions with ABCC2
  197. Protective effects of 4-methylcoumarins and related compounds as radical scavengers and chain-breaking antioxidants
  198. Long Chain Alkyl Esters of Hydroxycinnamic Acids as Promising Anticancer Agents: Selective Induction of Apoptosis in Cancer Cells
  199. Controversy about pharmacological modulation of Nrf2 for cancer therapy
  200. The Role Of Oxidative Stress Modulators In Breast Cancer
  201. Antioxidant activity of phenolic compounds from extracts of Eucalyptus globulus and Melaleuca styphelioides and their protective role on D-glucose-induced hyperglycemic stress and oxalate stress in NRK-49Fcells
  202. Derivatives of caffeic acid, a natural antioxidant, as the basis for the discovery of novel nonpeptidic neurotrophic agents
  203. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
  204. The simple isocratic HPLC—UV method for the simultaneous determination of reduced and oxidized glutathione in animal tissue
  205. Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease
  206. Synthesis of new heterocyclic compounds based on pyrazolopyridine scaffold and evaluation of their neuroprotective potential in MPP + -induced neurodegeneration
  207. Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance
  208. Novel 5-oxo-hexahydroquinoline derivatives: design, synthesis, in vitro P-glycoprotein-mediated multidrug resistance reversal profile and molecular dynamics simulation study
  209. Detection of Reactive Oxygen and Nitrogen Species by Electron Paramagnetic Resonance (EPR) Technique
  210. Expression of heterologous oxalate decarboxylase in HEK293 cells confers protection against oxalate induced oxidative stress as a therapeutic approach for calcium oxalate stone disease
  211. Disulfiram moderately restores impaired hepatic redox status of rats subchronically exposed to cadmium
  212. Cardiovascular Mitochondrial Dysfunction Induced by Cocaine: Biomarkers and Possible Beneficial Effects of Modulators of Oxidative Stress
  213. Modulation of Oxidative Stress: Pharmaceutical and Pharmacological Aspects 2017
  214. Antimycobacterial activity of novel hydrazide-hydrazone derivatives with 2 H -chromene and coumarin scaffold
  215. Effect of organic co-solvents in the evaluation of the hydroxyl radical scavenging activity by the 2-deoxyribose degradation assay: The paradigmatic case of α-lipoic acid
  216. Tetrahydroquinolinone derivatives as potent P-glycoprotein inhibitors: design, synthesis, biological evaluation and molecular docking analysis
  217. Antioxidant activity and protective role on protein glycation of synthetic aminocoumarins
  218. Discovery of neurotrophic agents based on hydroxycinnamic acid scaffold
  219. Antiproliferative and antioxidative effects of novel hydrazone derivatives bearing coumarin and chromene moiety
  220. Synthesis and evaluation of antibacterial and antioxidant activity of novel 2-phenyl-quinoline analogs derivatized at position 4 with aromatically substituted 4H-1,2,4-triazoles
  221. Negletein as a neuroprotectant enhances the action of nerve growth factor and induces neurite outgrowth in PC12 cells
  222. Novel indole-based melatonin analogues: Evaluation of antioxidant activity and protective effect against amyloid β-induced damage
  223. Lanthanide(III) complexes are more active inhibitors of the Fenton reaction than pure ligands
  224. Cardiovascular and Hepatic Toxicity of Cocaine: Potential Beneficial Effects of Modulators of Oxidative Stress
  225. Modulation of Oxidative Stress: Pharmaceutical and Pharmacological Aspects
  226. Redox Control of Multidrug Resistance and Its Possible Modulation by Antioxidants
  227. Neuroprotective and Antioxidant Activities of 4-Methylcoumarins: Development of Structure–Activity Relationships
  228. Modulation of neurotrophic signaling pathways by polyphenols
  229. Oxidative stress, bioelements and androgen status in testes of rats subacutely exposed to cadmium
  230. The impact of Hydrogen peroxide on structure, stability and functional properties of Human R12C mutant αA-crystallin: The imperative insights into pathomechanism of the associated congenital cataract incidence
  231. Effective attenuation of atrazine-induced histopathological changes in testicular tissue by antioxidantN-phenyl-4-aryl-polyhydroquinolines
  232. Structure–activity relationship studies of 4-methylcoumarin derivatives as anticancer agents
  233. Inhibition of Alzheimer’s BACE-1 by 2,6-dialkyl-4-chromon-3-yl-1,4-dihydropyridine-3,5-dicarboxylates
  234. Kinase Inhibitors with Redox and Anti-inflammatory Activities
  235. Hypoglycemic activity of curcumin synthetic analogues in alloxan-induced diabetic rats
  236. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells
  237. Pleiotropic Effects of Statins in Atherosclerotic Disease: Focus on the Antioxidant Activity of Atorvastatin
  238. Multiple Mechanisms of Iron-Induced Amyloid Beta-Peptide Accumulation in SHSY5Y Cells: Protective Action of Negletein
  239. Carthamus, SalviaandStachysspecies protect neuronal cells against oxidative stress-induced apoptosis
  240. In vitro evaluation of copper-chelating properties of flavonoids
  241. Chromenone and quinolinone derivatives as potent antioxidant agents
  242. 4-Methylcoumarin Derivatives with Anti-inflammatory Effects in Activated Microglial Cells
  243. Comparison of Protein Acetyltransferase Action of CRTAase with the Prototypes of HAT
  244. Isoprostanes and Neuroprostanes as Biomarkers of Oxidative Stress in Neurodegenerative Diseases
  245. Resveratrol Counteracts Inflammation in Human M1 and M2 Macrophages upon Challenge with 7-Oxo-Cholesterol: Potential Therapeutic Implications in Atherosclerosis
  246. Editorial (Thematic Issue: Synthesis, Evaluation and Pharmacological Applications of Antioxidants- Part 1)
  247. Editorial (Thematic Issue: Synthesis, Evaluation and Pharmacological Applications of Antioxidants- Part 2)
  248. Antioxidant Activity of Galantamine and Some of its Derivatives
  249. Advances in Research of Schiff-Base Metal Complexes as Potent Antioxidants
  250. Oxidized Haemoglobin–Driven Endothelial Dysfunction and Immune Cell Activation: Novel Therapeutic Targets for Atherosclerosis
  251. Reversal of multidrug resistance in cancer cells by novel asymmetrical 1,4-dihydropyridines
  252. Protection of Cells against Oxidative Stress by Nanomolar Levels of Hydroxyflavones Indicates a New Type of Intracellular Antioxidant Mechanism
  253. Comparative specificities of Calreticulin Transacetylase to O-acetyl, N-acetyl and S-acetyl derivative of 4-methylcoumarins and their inhibitory effect on AFB1-induced genotoxicity in vitro and in vivo
  254. Editorial (Hot Topic: Antioxidant Heterocyclic Compounds in Drug Discovery and Medicinal Chemistry)
  255. Biotechnology in the Production of Pharmaceutical Industry Ingredients: Amino Acids
  256. Resveratrol Prevents Dendritic Cell Maturation in Response to Advanced Glycation End Products
  257. In vitro platelet antiaggregatory properties of 4-methylcoumarins
  258. Iron reduction potentiates hydroxyl radical formation only in flavonols
  259. An efficient and convenient microwave-assisted chemical synthesis of (thio)xanthones with additional in vitro and in silico characterization
  260. Alkyl esters of hydroxycinnamic acids with improved antioxidant activity and lipophilicity protect PC12 cells against oxidative stress
  261. Antiradical and antioxidant activities of new bio-antioxidants
  262. Modulatory effects of two novel agonists for serotonin receptor 7 on emotion, motivation and circadian rhythm profiles in mice
  263. Biomarkers of Subclinical Atherosclerosis in Patients with Autoimmune Disorders
  264. In vitro characteristics of 1-phenyl-3-methyl-4-acylpyrazol-5-ones iron chelators
  265. T Lymphocyte Autoreactivity in Inflammatory Mechanisms Regulating Atherosclerosis
  266. The mechanism of antioxidant activity of IRFI005 as a synthetic hydrophilic analogue of vitamin E
  267. Antioxidant Therapy: Current Status and Future Prospects
  268. Normalization of deranged signal transduction in lymphocytes of COPD patients by the novel calcium channel blocker H-DHPM
  269. Short- and long-term regulation of 3-hydroxy 3-methylglutaryl coenzyme A reductase by a 4-methylcoumarin
  270. Protein Acyltransferase Function of Purified Calreticulin: The Exclusive Role of P-Domain in Mediating Protein Acylation Utilizing Acyloxycoumarins and Acetyl CoA as the Acyl Group Donors
  271. In vitro analysis of iron chelating activity of flavonoids
  272. Advanced glycation end products of human  2 glycoprotein I modulate the maturation and function of DCs
  273. Dietary Phenolic Acids and Derivatives. Evaluation of the Antioxidant Activity of Sinapic Acid and Its Alkyl Esters
  274. Optimization of Lipase Production from Aspergillus terreus by Response Surface Methodology and Its Potential for Synthesis of Partial Glycerides Under Solvent Free Conditions
  275. Novel coumarin-based tyrosinase inhibitors discovered by OECD principles-validated QSAR approach from an enlarged, balanced database
  276. 4-Methylcoumarins as antioxidants: Scavenging of peroxyl radicals and inhibition of human low-density lipoprotein oxidation
  277. A spectroelectrochemical and chemical study on oxidation of 7,8-dihydroxy-4-methylcoumarin (DHMC) and some related compounds in aprotic medium
  278. Antioxidant properties of 4-methylcoumarins in in vitro cell-free systems
  279. In vitro interactions of coumarins with iron
  280. Structure–activity relationship of dihydroxy-4-methylcoumarins as powerful antioxidants: Correlation between experimental & theoretical data and synergistic effect
  281. β-sitosterol among other secondary metabolites of Piper galeatum shows inhibition of TNFα-induced cell adhesion molecule expression on human endothelial cells
  282. Protein acyltransferase function of purified calreticulin. Part 1: characterization of propionylation of protein utilizing propoxycoumarin as the propionyl group donor
  283. Home cage testing of delay discounting in rats
  284. Resilience and vulnerability are dose-dependently related to neonatal stressors in mice
  285. Phycocyanin liposomes for topical anti-inflammatory activity: in-vitro in-vivo studies
  286. Phycocyanin liposomes for topical anti-inflammatory activity: in-vitro in-vivo studies
  287. Inhibition of zymosan-induced kidney dysfunction by tyrphostin AG-490
  288. The Role of Calreticulin Transacetylase in the Activation of Human Platelet Nitrite Reductase by Polyphenolic Acetates
  289. Non-native glyceraldehyde-3-phosphate dehydrogenase can be an intrinsic component of amyloid structures
  290. Autoacetylation of Purified Calreticulin Transacetylase Utilizing Acetoxycoumarin as the Acetyl Group Donor
  291. Autoacetylation of Purified Calreticulin Transacetylase Utilizing Acetoxycoumarin as the Acetyl Group Donor
  292. Inhibition of Candida albicans extracellular enzyme activity by selected natural substances and their application inCandidainfection
  293. Calreticulin Transacetylase Catalyzed Activation of Rat Tracheal Smooth Muscle Cell Nitric Oxide Synthase by Acetoxycoumarins
  294. Behavioral effects of 6-bromoflavanone and 5-methoxy-6,8-dibromoflavanone as anxiolytic compounds
  295. DPPH Radical Scavenging Activity of Several Naturally Occurring Coumarins and Their Synthesized Analogs Measured by the SIA Method
  296. Protein oxidation markers in the serum and synovial fluid of psoriatic arthritis patients
  297. Antioxidant activity of 4-methylcoumarins
  298. Themed Issue:Chemistry and Biology of Antioxidants
  299. Specific oxidative stress parameters differently correlate with nailfold capillaroscopy changes and organ involvement in systemic sclerosis
  300. Antioxidant and prooxidant effects of quercetin on glyceraldehyde-3-phosphate dehydrogenase
  301. Interaction of Polyelectrolytes with Proteins, 3
  302. Synthesis of Deoxy Sugar Esters:  A Chemoenzymatic Stereoselective Approach Affording Deoxy Sugar Derivatives Also in the Form of Aldehyde
  303. Decrease of dehydrogenase activity of cerebral glyceraldehyde-3-phosphate dehydrogenase in different animal models of Alzheimer's disease
  304. Helicobacter pylori EstV: Identification, Cloning, and Characterization of the First Lipase Isolated from an Epsilon-Proteobacterium
  305. A spectroelectrochemical and chemical study on oxidation of hydroxycinnamic acids in aprotic medium
  306. Effect of α-crystallin on thermal denaturation and aggregation of rabbit muscle glyceraldehyde-3-phosphate dehydrogenase
  307. Effect of infliximab on the glycosylation of IgG of patients with rheumatoid arthritis
  308. Mechanism of Thermal Aggregation of Rabbit Muscle Glyceraldehyde-3-phosphate Dehydrogenase†
  309. Oxidative stress parameters in different systemic rheumatic diseases
  310. Preface
  311. Inhibition of Candida rugosa lipase by saponins, flavonoids and alkaloids
  312. Propionibacterium acnes GehA lipase, an enzyme involved in acne development, can be successfully inhibited by defined natural substances
  313. Parameters of oxidative stress status in healthy subjects: their correlations and stability after sample collection
  314. Interaction of Polyanions with Basic Proteins, 2
  315. Long-term effects of lonidamine on mouse testes
  316. Lonidamine transiently affects spermatogenesis in pubertal CD1 mice
  317. Preface: male infertility, from contraception to therapy
  318. Identification of a carboxylesterase-producingRhodococcussoil isolate
  319. Ibogaine reduces organ colonization in murine systemic and gastrointestinal Candida albicans infections
  320. Atractylis gummifera L. poisoning: an ethnopharmacological review
  321. Evaluation of the antioxidant activity of flavonoids by “ferric reducing antioxidant power” assay and cyclic voltammetry
  322. Activation and inhibition of Candida rugosa and Bacillus-related lipases by saturated fatty acids, evaluated by a new colorimetric microassay
  323. Hypochlorite scavenging activity of flavonoids
  324. Hypochlorite scavenging activity of hydroxycinnamic acids evaluated by a rapid microplate method based on the measurement of chloramines
  325. Preface
  326. Development of a new assay for the screening of hypochlorous acid scavengers based on reversed-phase high-performance liquid chromatography
  327. Indazole carboxylic acids in male contraception
  328. Lipocalin type prostaglandin D-synthase: which role in male fertility?
  329. Recent studies on lonidamine, the lead compound of the antispermatogenic indazol-carboxylic acids
  330. The controversial efficacy of vitamin E for human male infertility
  331. Antimicrobial and Anti-Lipase Activity of Quercetin and its C2-C16 3-O-Acyl-Esters
  332. Corneal Toxicity of Xylazine and Clonidine, in Combination with Ketamine, in the Rat
  333. Analgesic properties of Epilobium angustifolium, evaluated by the hot plate test and the writhing test
  334. Anti-proliferative effect on a prostatic epithelial cell line (PZ-HPV-7) by Epilobium angustifolium L.
  335. Inhibition of heat-induced denaturation of albumin by nonsteroidal antiinflammatory drugs (NSAIDs): Pharmacological implications
  336. Inhibition of calcium oxalate precipitation by bile salts
  337. Analysis of lonidamine in rat serum and testis by high performance liquid chromatography
  338. Antidenaturant drugs for cataract and other condensation diseases
  339. In vitro evaluation of antioxidant activity by electrophoresis and high performance liquid chromatography
  340. Relaxant Effects of Hydrastis canadensis L. and its Major Alkaloids on Guinea Pig Isolated Trachea
  341. Antimicrobial investigation of semipurified fractions of Ginkgo biloba leaves
  342. Stimulation of guinea pig isolated atria by aflatoxins
  343. Effects of lonidamine on testicular and epididymal proteins in the rat☆
  344. Relaxant Effects of Aflatoxins on Isolated Guinea Pig Trachea
  345. AFLATOXINS INHIBIT PROLACTIN SECRETION BY RAT PITUITARY CELLS IN CULTURE
  346. Simultaneous determination of hydrocortisone, dexamethasone, indomethacin, phenylbutazone and oxyphenbutazone in equine serum by high-performance liquid chromatography
  347. Micropurification of β- and γ-crystallins from rabbit aqueous humor
  348. Changes of Glycosylation of Serum Proteins in Sjogren's Syndrome: Correlation with Interleukin-6 and Soluble Interleukin-2 Receptor
  349. Stabilization of rat serum proteins following oral administration of fish oil
  350. Development of an in vitro Assay for the Screening of Substances Capable of Dissolving Calcium Oxalate Crystals
  351. Development of an enzyme-linked immunosorbent assay, using a monoclonal antibody against α2-macroglobulin, for the diagnosis of systemic lupus erythematosus
  352. Changes in concanavalin A-reactive proteins in neurological disorders
  353. Inhibition of Protein Denaturation by Fatty Acids, Bile Salts and Other Natural Substances: A New Hypothesis for the Mechanism of Action of Fish Oil in Rheumatic Diseases.
  354. Inhibition ofCandida rugosaLipase by Berberine and Structurally Related Alkaloids, Evaluated by High-Performance Liquid Chromatography
  355. Development of a Turbidimetric Assay to Study the Effect of Urinary Components on Calcium Oxalate Precipitation
  356. Development of an HPLC Assay to Study the Effect of Endogenous and Exogenous Substances on Heat-Induced Aggregation of Human Serum Albumin
  357. Response of α2-Macroglobulin Messenger Ribonucleic Acid Expression to Acute Inflammation in the Testis is Different from the Response in the Liver and Brain1
  358. Abnormal glycosylation of ?2-macroglobulin, a non-acute-phase protein, in patients with autoimmune diseases
  359. The Use of High-Performance Electrophoresis Chromatography for the Micropurification of Cerebrospinal Fluid Proteins in the Rat
  360. Changes of immunoreactivity in ?1-antitrypsin in patients with autoimmune diseases
  361. Facilitating Effect of Amphetamine and Harmaline on Blood Pressure Response to Biogenic Amines in Rats
  362. In Vitro Antiproliferative Activity of Petiveria Alliacea L. on Several Tumor Cell Lines
  363. Persea Indica: General Pharmacological Effects of the Total Extract
  364. Regulation of Sertoli Cell α2-Macroglobulin and Clusterin (SGP-2) Secretion by Peritubular Myoid Cells1